{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:54:14Z","timestamp":1784998454752,"version":"3.55.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec>\n            <jats:title>Background and Purpose\u2014<\/jats:title>\n            <jats:p>Subarachnoid hemorrhage (SAH) accounts for &lt;7% of all strokes, but is an enormous individual and societal burden. We investigated the risk of SAH associated with prior use of antithrombotic drugs and their influence on 30-day case fatality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\u2014<\/jats:title>\n            <jats:p>We conducted a nested case\u2013control study in a cohort of 13.4 million members of the German Pharmacoepidemiological Research Database. Ten controls were matched to each case hospitalized for SAH between July 2004 and November 2006 by health insurance, year of birth, and sex using risk set sampling. Exposure was assessed for the warfarin analog phenprocoumon, heparin, clopidogrel\/ticlopidine, and acetylsalicylic acid. Multivariable-adjusted odds ratios (ORs) for SAH were estimated by conditional logistic regression. Risk factors for 30-day case fatality were assessed in patients with SAH by logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results\u2014<\/jats:title>\n            <jats:p>The nested case\u2013control study included 2065 SAH cases and 20\u2009649 matched controls. The risk of SAH was significantly increased for phenprocoumon (OR, 1.7; 95% confidence interval [CI], 1.3\u20132.3), clopidogrel\/ticlopidine (OR, 1.7; 95% CI, 1.1\u20132.5), and for acetylsalicylic acid use (OR, 1.5; 95% CI, 1.2\u20132.0), but not for outpatient heparin use (OR, 1.2; 95% CI, 0.5\u20132.7). The early case fatality of 22.8% was associated with an age &gt;70 years (OR, 2.3; 95% CI, 1.8\u20133.1) and arterial hypertension (OR, 1.3; 95% CI, 1.0\u20131.6), but not with any of the antithrombotic drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>Outpatient antithrombotic drug use was associated with an increased risk of SAH, but no association was observed with early case fatality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/strokeaha.111.000811","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T07:57:00Z","timestamp":1372492620000},"page":"2422-2426","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Risk of Subarachnoid Hemorrhage and Early Case Fatality Associated With Outpatient Antithrombotic Drug Use"],"prefix":"10.1161","volume":"44","author":[{"given":"Edeltraut","family":"Garbe","sequence":"first","affiliation":[{"name":"From the Departments of Clinical Epidemiology (E.G.), and Biometry and Data Management (S.B.), Leibniz Institute for Prevention Research and Epidemiology\u2013BIPS, Bremen, Germany; Faculty of Social and Health Sciences, University of Bremen, Bremen, Germany (E.G.); and Department of Psychiatry and Psychotherapy Bethel, Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany (S.H.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Kreisel","sequence":"additional","affiliation":[{"name":"From the Departments of Clinical Epidemiology (E.G.), and Biometry and Data Management (S.B.), Leibniz Institute for Prevention Research and Epidemiology\u2013BIPS, Bremen, Germany; Faculty of Social and Health Sciences, University of Bremen, Bremen, Germany (E.G.); and Department of Psychiatry and Psychotherapy Bethel, Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany (S.H.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Behr","sequence":"additional","affiliation":[{"name":"From the Departments of Clinical Epidemiology (E.G.), and Biometry and Data Management (S.B.), Leibniz Institute for Prevention Research and Epidemiology\u2013BIPS, Bremen, Germany; Faculty of Social and Health Sciences, University of Bremen, Bremen, Germany (E.G.); and Department of Psychiatry and Psychotherapy Bethel, Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany (S.H.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.117655"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000190838.02954.e8"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1413"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60153-6"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70025-0"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70126-7"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5660-y"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000014773.57733.3e"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.1.251"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.5.1173"},{"key":"e_1_3_3_12_2","first-page":"425","volume-title":"In: Arzneiverordnungsreport","author":"Hein L","year":"2007","unstructured":"Hein L, Schwabe U. Antikoagulantien und Thrombozytenaggregationshemmer. , Schwabe U, Paffrath D, eds. In: Arzneiverordnungsreport. Heidelberg: Springer Medizin Verlag; 2007:425\u2013438."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544120-00003"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3193"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1031-6"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1973"},{"key":"e_1_3_3_17_2","first-page":"S294","article-title":"Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database.","volume":"19","author":"Schink T","year":"2010","unstructured":"Schink T, Garbe E. Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf. 2010;19:S294. Abstract.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_3_3_18_2","first-page":"111","volume-title":"In: Modern Epidemiology","author":"Rothman KJ","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL. Case-Control Studies. , Rothman KJ, Greenland S, Lash TL, eds. In: Modern Epidemiology. 3 rd. Philadelphia, PA: Lippincott Williams & Wilkens; 2008:111\u2013127.","edition":"3"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009523"},{"key":"e_1_3_3_20_2","author":"EUROSTAT-Europe in Figures","unstructured":"EUROSTAT-Europe in Figures. Eurostat yearbook 2008. Available at: URL: http:\/\/epp.eurostat.ec.europa.eu. Accessed: April 3, 2013.","journal-title":"Eurostat yearbook 2008"},{"key":"e_1_3_3_21_2","unstructured":"International Agency for Research on Cancer. Statistical Methods in Cancer Research - Volume II - The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82. Available at: URL: http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/stat\/sp82\/SP82.pdf. 1987. Accessed: April 3 2013."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04170.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.04.009"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03856.x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9432-x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1545"},{"key":"e_1_3_3_27_2","first-page":"S178","article-title":"Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database.","volume":"19","author":"Schink T","year":"2010","unstructured":"Schink T, Garbe E. Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf. 2010;19:S178\u2013S179. Abstract.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.112.674291"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.111.000811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T13:58:50Z","timestamp":1715608730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.111.000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1161\/STROKEAHA.111.000811"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.111.000811","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"2013-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}